These BBN-induced tumors closely recapitulate the mutational landscape of human MIBC, particularly alterations in TP53, RAS, and H19 (involved in regulating cell proliferation and tumor progression), with a high mutational burden and basal subtype features [6, 7]. This evidence concerns the gene TP53 and neoplasm.